High throughput functional screening for next generation cancer immunotherapy using droplet-based microfluidics

Currently high throughput approaches are lagged for isolation of antibodies whose function goes beyond simple binding, which have prevented the next generation cancer immunotherapeutics, such as bispecific T cell engager antibodies or agonist antibody of costimulatory receptor, from reaching their full potential. Here we developed a highly efficient droplet-based microfluidics platform combining with lentivirus transduction system that enables functional screening of millions of antibodies. To showcase the capacity of the system, functional antibodies for CD40 agonism with low frequency (<0.02%) were identified with 2 rounds of screening. To demonstrate its versatility, an anti-Her2/anti-CD3 bispecific antibody library was established using bispecific T cell Engager (BiTE) platform and functional screening enabled efficient identification of potent anti-Her2/anti-CD3 BiTE antibodies. The platform could revolutionize the next generation cancer immunotherapy drug development and research world.

[1]  Jamie B. Spangler,et al.  Insights into cytokine-receptor interactions from cytokine engineering. , 2015, Annual review of immunology.

[2]  S. Elledge,et al.  T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes , 2019, Cell.

[3]  John McCafferty,et al.  Beyond natural antibodies: the power of in vitro display technologies , 2011, Nature Biotechnology.

[4]  Axel Hoos,et al.  Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies , 2016, Nature Reviews Drug Discovery.

[5]  Christoph A. Merten,et al.  Droplet-based microfluidics in drug discovery, transcriptomics and high-throughput molecular genetics. , 2016, Lab on a chip.

[6]  A. Plückthun,et al.  In vitro display technologies: novel developments and applications. , 2001, Current opinion in biotechnology.

[7]  Janice M Reichert,et al.  Bispecific antibodies: a mechanistic review of the pipeline , 2019, Nature Reviews Drug Discovery.

[8]  R. Lerner,et al.  Selection of antibodies that regulate phenotype from intracellular combinatorial antibody libraries , 2012, Proceedings of the National Academy of Sciences.

[9]  Christoph A. Merten,et al.  Single-Cell Droplet Microfluidic Screening for Antibodies Specifically Binding to Target Cells , 2018, Cell reports.

[10]  D. Weitz,et al.  Single-cell analysis and sorting using droplet-based microfluidics , 2013, Nature Protocols.

[11]  H. Stone,et al.  Formation of dispersions using “flow focusing” in microchannels , 2003 .

[12]  David Baker,et al.  Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes , 2018, Science.

[13]  Richard A Lerner,et al.  Manufacturing immunity to disease in a test tube: the magic bullet realized. , 2006, Angewandte Chemie.

[14]  R. Vonderheide.  CD40 Agonist Antibodies in Cancer Immunotherapy. , 2020, Annual review of medicine.

[15]  S. Quake,et al.  The promise and challenge of high-throughput sequencing of the antibody repertoire , 2014, Nature Biotechnology.

[16]  G. Whitesides,et al.  Poly(dimethylsiloxane) as a material for fabricating microfluidic devices. , 2002, Accounts of chemical research.

[17]  R. Minter,et al.  A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency , 2012, Cell Death and Differentiation.

[18]  D. Vignali,et al.  Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups , 2019, Nature Immunology.

[19]  J. Baudry,et al.  High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics , 2020, Nature Biotechnology.

[20]  Christos Stathopoulos,et al.  Display of heterologous proteins on the surface of microorganisms: From the screening of combinatorial libraries to live recombinant vaccines , 1997, Nature Biotechnology.

[21]  M. Friedrich,et al.  T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells , 2010, Proceedings of the National Academy of Sciences.

[22]  R. Lerner,et al.  Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects , 2015, Nature Communications.

[23]  Andrew D Griffiths,et al.  Single-cell deep phenotyping of IgG-secreting cells for high-resolution immune monitoring , 2017, Nature Biotechnology.

[24]  Christoph A. Merten,et al.  Functional single-cell hybridoma screening using droplet-based microfluidics , 2012, Proceedings of the National Academy of Sciences.

[25]  Vanessa M. Hubbard-Lucey,et al.  Trial watch: The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors , 2018, Nature Reviews Drug Discovery.

[26]  George P Smith,et al.  Phage Display: Simple Evolution in a Petri Dish (Nobel Lecture). , 2019, Angewandte Chemie.

[27]  D. Weitz,et al.  Sorting drops and cells with acoustics: acoustic microfluidic fluorescence-activated cell sorter. , 2014, Lab on a chip.

[28]  Eric T. Boder,et al.  Yeast surface display for screening combinatorial polypeptide libraries , 1997, Nature Biotechnology.

[29]  A. Hoos,et al.  The promise and challenges of immune agonist antibody development in cancer , 2018, Nature Reviews Drug Discovery.

[30]  E. Song,et al.  Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics , 2020, Cellular & Molecular Immunology.